Cephalexin (Cephalexin Pharma Q, Cephalexin Dry Pharma-q)
Cephalexin
Pharma-q Holdings (Pty) Ltd
Registration
- Applicant
- Pharma-q Holdings (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cephalexin 250 pharma q EACH CAPSULE CONTAINS CEPHALEXIN 250 mg | 250 | 29012429/20.1.1/0124 | Registered | Not determined | None |
| Cephalexin 500 pharma q EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN | 500 | 29012529/20.1.1/0125 | Registered | Not determined | None |
| Cephalexin dry syrup pharma-q EACH 5 ml SYRUP CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125,0 mg ANHYDROUS CEPHALEXIN | Syrup | 29012629/20.1.1/0126 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 27447.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.